SI - Shoulder Innovations, Inc. So'nggi... | Finranks

01.09.2026

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

GRAND RAPIDS, Mich., Sept. 1, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in a fireside chat at the Morgan Stanley 24th Annual Healthcare Conference.

10.08.2026

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

GRAND RAPIDS, Mich., Aug. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026.

09.08.2026

Shoulder Innovations Q2 Earnings Call Highlights

Shoulder Innovations NYSE: SI reported second-quarter net revenue of $17.2 million, up 56% from $11 million a year earlier, as the company added surgeons, expanded use among existing customers and advanced several product launches. The company raised its full-year 2026 revenue outlook to $67 million to $69 million, from a prior range of $65 million to $68 million.

07.08.2026

Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript

07.08.2026

Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates

Shoulder Innovations, Inc. (SI) came out with a quarterly loss of $0.46 per share in line with the Zacks Consensus Estimate. This compares to a loss of $64.47 per share a year ago.

06.08.2026

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Generates First Half 2026 Revenue Growth of 60% GRAND RAPIDS, Mich., Aug. 6, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the second quarter ended June 30, 2026.

Videolar

No Data

There is no data to display

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
SI	UBS	Buy	undefined >> $27	July 28th 2026

Press-relizlar

01.09.2026

Shoulder Innovations, Inc. (SI)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Shoulder Innovations, Inc. (SI)

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Q2 Earnings Call Highlights

Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript

Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Search stocks

Shoulder Innovations, Inc. (SI)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Shoulder Innovations, Inc. (SI)

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Q2 Earnings Call Highlights

Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript

Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook